Affiliation:
1. School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing
2. Department of Rehabilitation Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
3. Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China
Abstract
Acupuncture can reduce blood pressure, heart rate (HR), and ameliorate cardiac damage by modulating the excitability of the sympathetic nervous system, but the exact mechanism of this effect remains unclear. This study investigated the potential mechanisms of acupuncture in the treatment of cardiac damage in hypertension. Spontaneously hypertensive rats (SHR) were used as the hypertension model with Wistar–Kyoto rats as the control. Manual acupuncture, electroacupuncture, and metoprolol were used as interventions. Systolic and diastolic blood pressure (SBP, DBP) plus HR were monitored with cardiac structure determined using Masson staining. Angiotensin II (Ang II) and norepinephrine in myocardium were detected with ELISA as was Ang(1-7) and gamma aminobutyric acid (GABA) in the rostral ventrolateral medulla (RVLM). Expression of mRNA for collagen type I (Col-I), Col-III, actin α1 (ACTA1), and thrombospondin 4 (THBS4) in myocardium was detected using real-time PCR. Expression of angiotensin converting enzyme (ACE), Ang II, angiotensin II type 1 receptor (AT1R), ACE2, and Mas receptor (MasR) proteins in RVLM was monitored using western blot. After manual acupuncture and electroacupuncture treatment, SHRs showed decreased SBP, DBP and HR, reduced myocardial damage. There was decreased expression of the ACE/Ang II/AT1R axis, and increased expression of the ACE2/Ang(1-7)/MasR axis within the RVLM. GABA levels were increased within the RVLM and norepinephrine levels were decreased in myocardial tissue. Metoprolol was more effective than either manual acupuncture or electroacupuncture. Acupuncture directed against hypertensive cardiac damage may be associated with regulation of ACE/Ang II/AT1R and the ACE2/Ang(1-7)/MasR pathway within the RLVM to reduce cardiac sympathetic excitability.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. National Health and Family Planning Commission Expert Committee on Rational Use of Medicines Chinese Medical Doctors Association Hypertension Specialized Committee. Guide to the rational use of drugs for hypertension.;Chinese Journal of Frontiers in Medicine (electronic version),2017
2. Relationship between central sympathetic activity and stages of human hypertension.;Smith;Am J Hypertens,2004
3. Study on the stabilizing antihypertensive and cardioprotective effects of aliskiren on spontaneously hypertensive rats.;Zhai;Tianjin Medicine,2022
4. The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.;Mirza;J Biol Chem,2007
5. The thrombospondins.;Adams;Cold Spring Harb Perspect Biol,2011